{"schema_version":"secwatch.filing_event.v1","accession":"0001021771-21-000099","form_type":"8-K","ticker":"BRTX","cik":"0001505497","company_name":"BioRestorative Therapies, Inc.","filed_at":"2021-12-08T23:59:59+00:00","discovered_at":"2026-05-14T18:04:12.786542+00:00","generated_at":"2026-06-28T02:48:21.486202+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"BioRestorative Therapies enters CFO employment agreement with $175K salary, stock option grant","bullets":["CFO Robert E. Kristal employment agreement effective Nov 4, 2021, term through Nov 4, 2022.","Annual salary of $175,000; eligible for discretionary bonus up to 30% of salary.","Granted 10-year option to purchase 10,490 shares at $13.50 per share.","Severance: if terminated without cause or resigns for good reason, receives lesser of remaining salary or 25% of current salary, paid over 3 months.","One-year post-employment non-compete covering stem-cell therapy businesses in the US."],"urls":{"canonical":"https://secwatch.observer/filing/0001021771-21-000099","json":"https://secwatch.observer/filing/0001021771-21-000099.json","markdown":"https://secwatch.observer/filing/0001021771-21-000099.md","text":"https://secwatch.observer/filing/0001021771-21-000099.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1505497/000102177121000099/0001021771-21-000099-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1505497/000102177121000099/form8kdtd120321.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T02:48:21.486202+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}